Compliance with the treatment of hypertension: the potential of combination therapy.
about
Long-term safety and efficacy of telmisartan/amlodipine single pill combination in the treatment of hypertensionHow well do we care for patients with hypertension?Catheter-based renal sympathetic denervation: chronic preclinical evidence for renal artery safety.New perspectives on chinese herbal medicine (zhong-yao) research and developmentRenal denervation using focused infrared fiber lasers: a potential treatment for hypertension.The polypill in the primary prevention of cardiovascular disease: cost-effectiveness in the Dutch population.Perceptions of hypertension treatment among patients with and without diabetesOne year follow-up effect of renal sympathetic denervation in patients with resistant hypertension.Comparisons of the pharmacokinetics and tolerability of fixed-dose combinations of amlodipine besylate/losartan and amlodipine camsylate/losartan in healthy subjects: a randomized, open-label, single-dose, two-period, two-sequence crossover study.Angiotensin II receptor blocker combinations: from guidelines to clinical practice.Single-pill vs free-equivalent combination therapies for hypertension: a meta-analysis of health care costs and adherence.Improving treatment adherence to antihypertensive therapy: the role of single-pill combinations.Larger Blood Pressure Reduction by Fixed-Dose Compared to Free Dose Combination Therapy of ACE Inhibitor and Calcium Antagonist in Hypertensive Patients.Antihypertensive response to combination of olmesartan and amlodipine does not depend on method and time of drug administration.Pharmacokinetic and bioequivalence study of a telmisartan/S-amlodipine fixed-dose combination (CKD-828) formulation and coadministered telmisartan and S-amlodipine in healthy subjects.Patient adherence in the treatment of hypertension: the role of combination therapies.Self-reported adherence to therapeutic regimens among patients with hypertension.
P2860
Q26824261-B51AC033-93A5-4946-9FE1-F4E8A1CE75F1Q27006514-3C141950-6641-4E6B-BBD1-EE17CC060A1CQ34204205-C588E525-2C64-455C-A0F5-5D5DA8250B7CQ35102748-4C9F1FD8-7AF9-4473-AD72-BF6C2C1066CCQ35235028-6535A43C-9D0A-494C-9795-941BE31F016FQ35753875-FF7DC2D7-EE27-4876-9BD1-49F30711AF86Q35963314-64960CCC-4F07-41BE-8749-131B005F80CAQ37067196-9A591565-F0CD-4D13-9D9D-FC7485D1D832Q37283350-CDC930CC-A776-436C-AE08-5665DE3336CAQ37914851-4B12265D-F4E2-4842-84DF-139EA4C8CFB3Q37964788-6F032582-B60E-4C08-BF71-7F94BE10821DQ37973403-A53D87DD-BED1-441B-8DB1-6713C35C4213Q38641909-823E8F9C-4190-42DC-A2C5-28F8E301BAA2Q45137855-5C6B8EA6-9ACE-45A1-B11A-99DE6D42894FQ51244807-27BF9B4F-047D-4414-AB54-66FC369E7828Q51811904-7881A28B-C64C-4559-9D5A-947D6632037AQ54263956-94399FE9-C26F-4006-949A-1276A71F81B4
P2860
Compliance with the treatment of hypertension: the potential of combination therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Compliance with the treatment of hypertension: the potential of combination therapy.
@en
Compliance with the treatment of hypertension: the potential of combination therapy.
@nl
type
label
Compliance with the treatment of hypertension: the potential of combination therapy.
@en
Compliance with the treatment of hypertension: the potential of combination therapy.
@nl
prefLabel
Compliance with the treatment of hypertension: the potential of combination therapy.
@en
Compliance with the treatment of hypertension: the potential of combination therapy.
@nl
P1476
Compliance with the treatment of hypertension: the potential of combination therapy.
@en
P2093
Serap Erdine
P2860
P356
10.1111/J.1751-7176.2009.00200.X
P577
2010-01-01T00:00:00Z